Weight loss as a predictor of mortality in patients with interstitial lung disease

The interstitial lung diseases (ILDs) are a diverse group of diffuse parenchymal lung disorders that commonly result in pulmonary fibrosis. ILDs are broadly classified according to known and unknown aetiologies. Connective tissue disease-associated ILD (CTD-ILD) and chronic hypersensitivity pneumonitis (CHP) are among the most common ILDs of known aetiology, while idiopathic pulmonary fibrosis (IPF) and unclassifiable ILD (U-ILD) are among the most common of unknown aetiology [1–4]. Weight loss in patients with ILD was associated with increased mortality risk in those with IPF and U-ILD <http://ow.ly/Nk0D30l2Apm>